CVRx, Inc.
Develops & commercializes neuromodulation therapies for heart failure patients.
CVRX | US
Overview
Corporate Details
- ISIN(s):
- US1266381052
- LEI:
- Country:
- United States of America
- Address:
- 9201 WEST BROADWAY AVENUE, 55445 MINNEAPOLIS
- Website:
- https://www.cvrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of irradiation, electromedical and electrotherapeutic equipment
Description
CVRx, Inc. is a commercial-stage medical device company focused on developing and commercializing innovative neuromodulation therapies for patients with cardiovascular diseases. The company's flagship product is Barostim™, the world's first neuromodulation device designed to treat the symptoms of heart failure. Barostim utilizes Baroreflex Activation Therapy, an implantable technology that stimulates the body's natural baroreflex system to improve cardiovascular function. This therapy aims to enhance the quality of life, exercise capacity, and overall symptoms for heart failure patients who are not adequately managed by standard medications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CVRx, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CVRx, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CVRx, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
